Skip to content

APOTHEEK PUT

Active Private limited companyfounded 2006active for 20 yearsDiesterstraat 15, 3980 Tessenderlo-HamKBO/BCE: BE 0884.692.260 subsidiary of

Lifetime

19 annual accounts with figures on one time axis
peak of €245,940 in 2025
€245,940▲ 37.3%
lowest -€58,863 in 2017
€8,200▼ 52.2%
peak of €187,013 in 2025
€187,013▲ 4.6%
€421,570▲ 0.6%
peak of 2.6 FTE in 2025
2.6 FTE▲ 36.8%
Board3 names since 2021
2 directors and 1 other
Owners2 names in the annual accounts
99.5% and 1 other
Documentsfilings and deeds
18-08-202618 days late
2025abbreviated format
Gross margin from €179,178 to €245,940Result from €17,169 to €8,200Staff from 1.9 FTE to 2.6 FTECash from €221,962 to €108,749

Key points

from the 2025 annual accounts

Equity

€187,013 ▲ 4.6%

APOTHEEK PUT has made a profit without a break since 2018.

Turnover

≈ €1.2m estimated

The abbreviated format states no turnover.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2025 accounts came in latest, 18 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,047 companies had the same profile as APOTHEEK PUT has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,047 companies, not a prediction for APOTHEEK PUT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
Director
  • 99.5%equity €2.7m (2025) · annual accounts 30-06-2025 of
  • 0.5%score equity €968,257 (2025) · annual accounts 30-09-2025 of
Board & ownership

Recent changes

Environmental permit granted Nieuwe publiciteitsinrichting (met inbegrip van vernieuwen van een bestaande vergunning) · Tessenderlo-Ham
Registered in the Peppol Directory Reachable for e-invoices through 0208:0884692260
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · and act as permanent representatives · General meeting of 25-10-2023 · Gazette deed
Incorporation published on 10-11-2006 · Gazette deed
All 30 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK PUT Tessenderlo-Ham €608,583 €245,940 30.7% 2.6
APOTHEEK QUEENS Turnhout €621,995 €225,942 50.0% 2.5
LIBO CONSULT Halen €552,036 €287,132 10.1% 2.9
APOTHEEK MATTHIJS Huldenberg €564,034 €259,073 60.4% 2.9
PHARMACIE PIEDBOEUF Chaudfontaine €690,407 €263,956 6.7% 2.4
Apotheek Lozie Zele €687,772 €234,547 70.6% 2.4
MAERTENS PHARMA ASSOCIES Chimay €583,944 €266,463 59.0% 2.5

These companies have the same main activity as APOTHEEK PUT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €552,000 and €690,000, founded between 2003 and 2009.

Official details

Source: KBO
Status
Active since 31-10-2006Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.158.106.9733980 Tessenderlo-Ham, since 31-10-2006
Financial year end
31 December
Peppol
Reachable since 11-12-2025
Company details

Annual accounts 2025

€608,583▲ 1.8%
Employeeson 31-12-2025
3=
Filing
Filed on 18-08-2026
Financials

Insights on APOTHEEK PUT

APOTHEEK PUT files the abbreviated format. That format states no turnover. The gross margin rose from €34,706 in 2007 to €245,940 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK PUT

What is the company number of APOTHEEK PUT?
The company number of APOTHEEK PUT is 0884.692.260. The VAT number is the same number with BE in front: BE 0884.692.260.
Where is APOTHEEK PUT based?
The registered office is at Diesterstraat 15, 3980 Tessenderlo-Ham.Company details
What does APOTHEEK PUT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK PUT?
APOTHEEK PUT is a private limited company (BV).
When was APOTHEEK PUT founded?
APOTHEEK PUT was founded on 31-10-2006.
Is APOTHEEK PUT still active?
Yes, APOTHEEK PUT is an active enterprise in the KBO register.
How many employees does APOTHEEK PUT have?
APOTHEEK PUT had an average of 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK PUT fall under?
In its 2025 annual accounts, APOTHEEK PUT states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK PUT?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €245,940 and 43 comparable companies (NACE 477). It probably lies between €760,000 and €2.4m.
Is APOTHEEK PUT profitable?
In financial year 2025, APOTHEEK PUT made a profit of €8,200.
Where can I find the annual accounts of APOTHEEK PUT?
APOTHEEK PUT filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK PUT due?
APOTHEEK PUT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.